Jump to main content
Jump to site search

Issue 42, 2015
Previous Article Next Article

Facile synthesis of yolk–shell silica nanoparticles for targeted tumor therapy

Author affiliations

Abstract

Yolk–shell mesoporous silica nanoparticles (YMSNs) were synthesized via a facile approach. The YMSNs displayed a relatively uniform size, good dispersity and hemocompatibility. The YMSNs were further used to construct a redox-responsive drug delivery system for targeted tumor therapy, by employing a special rotaxane nanovalve based on Pd as an end-capping agent, disulfide bonds as intermediate linkers and folic acid as a targeting motif. Various characterizations proved that the system had been successfully constructed. A series of biological assays demonstrated that the fabricated YMSN system could be triggered by intracellular glutathione for delivering the anticancer drug doxorubicin hydrochloride (DOX), leading to cell apoptosis in vitro. More importantly, the YMSN system displayed great potential for targeted tumor therapy in vivo, with minimal toxic side effects.

Graphical abstract: Facile synthesis of yolk–shell silica nanoparticles for targeted tumor therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 10 Aug 2015, accepted on 09 Sep 2015 and first published on 11 Sep 2015


Article type: Paper
DOI: 10.1039/C5TB01620G
Author version available: Download Author version (PDF)
Citation: J. Mater. Chem. B, 2015,3, 8303-8313
  •   Request permissions

    Facile synthesis of yolk–shell silica nanoparticles for targeted tumor therapy

    L. Dai, Q. Zhang, H. Gu and K. Cai, J. Mater. Chem. B, 2015, 3, 8303
    DOI: 10.1039/C5TB01620G

Search articles by author

Spotlight

Advertisements